| scholarly article | Q13442814 |
| P2093 | author name string | Nouf M Al-Rasheed | |
| Nawal M Al-Rasheed | |||
| Hala A Attia | |||
| Iman H Hasan | |||
| Raeesa A Mohamad | |||
| Maha Al-Amin | |||
| Hanaa Al-Ajmi | |||
| P2860 | cites work | Effect of lipoic acid on expression of angiogenic factors in diabetic rat retina | Q84916768 |
| Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent | Q28248838 | ||
| Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats | Q28484372 | ||
| Acute exercise and thioredoxin-1 in rat brain, and alpha-lipoic acid and thioredoxin-interacting protein response, in diabetes | Q28574328 | ||
| NAD(P)H oxidase: role in cardiovascular biology and disease | Q29616102 | ||
| Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction | Q29616762 | ||
| Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway. | Q30359509 | ||
| alpha-Lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2-*-generation | Q33214275 | ||
| alpha-Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1alpha signaling in the skeletal muscle of aged mice | Q33900969 | ||
| Is alpha-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity. | Q34011073 | ||
| Lipoic acid - biological activity and therapeutic potential | Q34029023 | ||
| The pharmacology of the antioxidant lipoic acid | Q34447239 | ||
| Alpha-lipoic acid in liver metabolism and disease | Q34747466 | ||
| Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid | Q34749673 | ||
| Oxidative stress and diabetic cardiomyopathy: a brief review | Q34817248 | ||
| New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy | Q35115544 | ||
| Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial | Q35179957 | ||
| Free radical-mediated oxidation of free amino acids and amino acid residues in proteins | Q35602220 | ||
| Disruption of redox homeostasis in tumor necrosis factor-induced apoptosis in a murine hepatocyte cell line | Q35745911 | ||
| Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy | Q35766956 | ||
| Oxidative stress and stress signaling: menace of diabetic cardiomyopathy | Q36204491 | ||
| NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. | Q36456363 | ||
| α-Lipoic acid attenuates cardiac fibrosis in Otsuka Long-Evans Tokushima Fatty rats | Q36571926 | ||
| Antioxidants in the treatment of diabetes | Q37835858 | ||
| Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart | Q38317335 | ||
| Prooxidant activities of alpha-lipoic acid on oxidative protein damage in the aging rat heart muscle | Q40432530 | ||
| Effect of alpha-lipoic acid supplementation on markers of protein oxidation in post-mitotic tissues of ageing rat. | Q40469766 | ||
| Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway | Q41149722 | ||
| Fas mediated apoptosis of human Jurkat T-cells: intracellular events and potentiation by redox-active alpha-lipoic acid | Q41674964 | ||
| Early expression of angiogenesis factors in acute myocardial ischemia and infarction | Q41722694 | ||
| R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes | Q42818712 | ||
| Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy. | Q43232861 | ||
| Mechanism of dihydrolipoate stimulation of the mitochondrial permeability transition: effect of different respiratory substrates | Q43504434 | ||
| Thiol oxidase activity of copper, zinc superoxide dismutase | Q43792229 | ||
| Neuronal death in the rat hippocampus in experimental diabetes and cerebral ischaemia treated with antioxidants | Q43841437 | ||
| The role of advanced oxidation protein products in regulation of dendritic cell function | Q43895324 | ||
| The amount of thiolic antioxidant ingestion needed to improve several immune functions is higher in aged than in adult mice. | Q43985437 | ||
| Activation of NADPH oxidase during progression of cardiac hypertrophy to failure | Q44167921 | ||
| Reactive oxygen species are involved in the stimulation of the mitochondrial permeability transition by dihydrolipoate. | Q44243157 | ||
| Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus | Q44268873 | ||
| Early oxidative stress in the diabetic kidney: effect of DL-alpha-lipoic acid | Q44274282 | ||
| Ageing exacerbates the cardiotoxicity of hydrogen peroxide through the Fenton reaction in rats | Q44360056 | ||
| Homocysteine strongly enhances metal-catalyzed LDL oxidation in the presence of cystine and cysteine | Q44430794 | ||
| Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats | Q44495010 | ||
| AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase | Q44504103 | ||
| Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver | Q45053341 | ||
| Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishme | Q45883055 | ||
| Effect of alpha-lipoic acid on LPS-induced oxidative stress in the heart. | Q46013820 | ||
| Effect of alpha lipoic acid on oxidative stress and vascular wall of diabetic rats. | Q46120092 | ||
| Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization | Q46271034 | ||
| Mechanisms of antioxidant and pro-oxidant effects of alpha-lipoic acid in the diabetic and nondiabetic kidney | Q46393330 | ||
| Pivotal role of gp91phox-containing NADH oxidase in lipopolysaccharide-induced tumor necrosis factor-alpha expression and myocardial depression | Q46408223 | ||
| Early lipoic acid intake protects retina of diabetic mice | Q46496432 | ||
| Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4. | Q46579574 | ||
| Plasma protein oxidation in aging rats after alpha-lipoic acid administration | Q46611302 | ||
| Thiol chelation of Cu2+ by dihydrolipoic acid prevents human low density lipoprotein peroxidation | Q46647777 | ||
| Pro-oxidant actions of alpha-lipoic acid and dihydrolipoic acid | Q46705618 | ||
| Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase | Q46823976 | ||
| Lipoic acid ameliorates oxidative stress and renal injury in alloxan diabetic rabbits. | Q46834219 | ||
| Effects of alpha-lipoic Acid on body weight in obese subjects | Q47399374 | ||
| Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes | Q47950327 | ||
| Effect of alpha-lipoic acid supplementation on trace element levels in serum and in postmitotic tissue in aged rats | Q48167186 | ||
| Safety evaluation of alpha-lipoic acid (ALA). | Q50078015 | ||
| Streptozotocin- and alloxan-induced diabetes modifies total plasma and lipoprotein lipid concentration and composition without altering cholesteryl ester transfer activity. | Q51490915 | ||
| alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. | Q51563349 | ||
| Alpha-lipoic acid inhibits glycogen synthesis in rat soleus muscle via its oxidative activity and the uncoupling of mitochondria. | Q52599694 | ||
| Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. | Q54167015 | ||
| The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. | Q55066548 | ||
| Comparison of the effect of α-lipoic acid and α-tocopherol supplementation on measures of oxidative stress | Q56608865 | ||
| Antioxidant Therapy in Diabetic Complications: What is New? | Q58829157 | ||
| Effects of Lipoic Acid and Dihydrolipoic Acid on 4-Aminophenol-Mediated Erythrocytic Toxicity in vitro | Q61959370 | ||
| Advanced oxidation protein products as a novel marker of oxidative stress in uremia | Q71324551 | ||
| Superoxide as an intracellular radical sink | Q72958737 | ||
| Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes | Q73572755 | ||
| Effects of oxidised alpha-lipoic acid and alpha-tocopherol on xenobiotic-mediated methaemoglobin formation in diabetic and non-diabetic human erythrocytes in-vitro | Q73925106 | ||
| Protein oxidative damage | Q74042771 | ||
| Effect of diabetes mellitus on formation of coronary collateral vessels | Q77393455 | ||
| Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue | Q77531118 | ||
| alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria | Q77988248 | ||
| Lipid peroxidation and antioxidant status in experimental diabetes | Q78099436 | ||
| Alpha-lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-kappaB transcriptional activity | Q79862188 | ||
| Effect of chronic restraint stress and alpha-lipoic acid on lipid peroxidation and antioxidant enzyme activities in rat peripheral organs | Q79899944 | ||
| Stimulation of membrane permeability transition by alpha-lipoic acid and its biochemical characteristics | Q80090787 | ||
| Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation | Q82155725 | ||
| Effect of pro- and antioxidants on insulin sensitivity and glucose tolerance | Q83218681 | ||
| General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid | Q83592593 | ||
| Amelioration of lipid abnormalities by α-lipoic acid through antioxidative and anti-inflammatory effects | Q84143689 | ||
| Role of lipoic acid on insulin resistance and leptin in experimentally diabetic rats | Q84823948 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 761-778 | |
| P577 | publication date | 2013-04-18 | |
| P1433 | published in | Journal of Physiology and Biochemistry | Q15751440 |
| P1476 | title | Adverse cardiac responses to alpha-lipoic acid in a rat-diabetic model: possible mechanisms? | |
| P478 | volume | 69 |
| Q46293158 | R-lipoic acid overdosing affects platelet life span via ROS mediated autophagy |
| Q28397610 | The effects of crocin, insulin and their co-administration on the heart function and pathology in streptozotocin-induced diabetic rats |
| Q89274818 | α-Lipoic Acid in Soluplus(®) Polymeric Nanomicelles for Ocular Treatment of Diabetes-Associated Corneal Diseases |
Search more.